[LGND] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
02-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- 69.70%
YoY- 39.12%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 45,693 72,473 64,835 84,675 55,150 69,990 41,848 6.04%
PBT -20,140 -7,026 15,259 33,301 5,764 3,370 -11,612 44.40%
Tax -4,755 -2,058 1,536 2,576 -12,342 -2,391 -4,911 -2.13%
NP -15,385 -4,968 13,723 30,725 18,106 5,761 -6,701 74.12%
Tax Rate - - -10.07% -7.74% 214.12% 70.95% - -
Total Cost 61,078 77,441 51,112 53,950 37,044 64,229 48,549 16.55%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -33.67 -6.85 21.17 36.29 32.83 8.23 -16.01 64.22%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.92 -0.30 0.82 1.84 1.10 0.36 -0.42 68.74%
EPS Diluted -0.91 -0.30 0.80 1.79 1.05 0.35 -0.42 67.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.